Achieve Facial Harmony: Facial Implants Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

Facial implants are solid biocompatible devices — most commonly made of medical-grade silicone — surgically placed over the facial skeleton to augment underdeveloped or deficient bony structures and create improved facial proportion, projection, and symmetry. The three most commonly requested facial implant sites are the chin (mentum), cheeks (malar/submalar region), and jawline (mandibular body and/or angle). Less commonly, implants are placed at the temporal region, nasal dorsum, or orbital rims.

The clinical rationale for facial implants lies in the recognition that facial attractiveness is substantially determined by underlying skeletal proportions. A weak chin (microgenia) makes the nose appear disproportionately large and the neck less defined. Flat cheekbones reduce midface projection and contribute to early nasolabial fold deepening with ageing. An underdeveloped jaw angle creates a less defined lower facial frame. By augmenting the deficient skeletal structure, facial implants address the underlying anatomical cause of disharmony rather than overlying soft tissue changes alone.

Surgical placement of facial implants is performed through incisions concealed inside the mouth (for chin and cheek implants, avoiding external scars) or in natural skin folds. The procedure is performed under general anaesthesia or deep intravenous sedation and takes 1–3 hours depending on the number and type of implants placed. Most patients are discharged the same day or the following morning.

Facial implants address congenital and developmental skeletal deficiencies, age-related skeletal resorption contributing to facial soft tissue descent, and post-traumatic facial deformities. The most common indications are: microgenia (underdeveloped chin causing poor facial profile balance, commonly associated with Class II malocclusion), malar hypoplasia (flat or underdeveloped cheekbones reducing midface projection), mandibular angle deficiency (absence of defined jaw angles creating a round or soft facial frame), and temporal hollowing (sunken temples contributing to an aged or gaunt appearance).

In reconstructive surgery, facial implants are used to restore facial contour after facial trauma with bone loss, tumour resection involving the facial skeleton, and congenital craniofacial conditions such as hemifacial microsomia. In gender-affirming facial feminisation or masculinisation surgery, facial implants (or their removal) may form part of the surgical plan to achieve the desired gender-congruent facial aesthetic.

Ideal candidates for facial implants are adults whose facial growth is complete (typically 18 years or older) with identifiable skeletal deficiencies — weak chin, flat cheekbones, absent jaw angles — that are causing facial disharmony or psychological distress. Good overall health, absence of active oral or facial infection, and realistic expectations about the achievable change in facial proportions are required. Digital imaging and anthropometric facial analysis assist in pre-surgical planning and expectations management.

Contraindications include active dental infections or periodontitis (significantly raising infection risk around intraoral implant placement), severe immune deficiency, autoimmune connective tissue disorders that impair wound healing or increase implant rejection risk, prior radiation to the face or jaw, and unresolved temporomandibular joint (TMJ) disorders that may be exacerbated by chin or jaw implants. Patients with severe dental malocclusion (overbite, underbite) that requires orthognathic surgery for functional correction are usually better served by corrective jaw surgery (genioplasty or osteotomy) rather than implants.

Facial implants are available in a wide range of sizes, shapes, and anatomical configurations, and can be custom-fabricated from 3D CT scan data for patients with complex asymmetry or post-traumatic defects. Standard silicone implants are most widely used due to their safety record, tactile properties, ease of insertion and revision, and stable long-term performance. Porous polyethylene (Medpor) implants allow soft tissue ingrowth for potentially more stable fixation but are less easily removed or revised.

For chin augmentation specifically, the alternative to alloplastic implant is a sliding genioplasty — an osteotomy procedure in which the chin bone is cut and repositioned, providing versatile three-dimensional correction of chin position but requiring a more complex operation and longer recovery. For isolated fat augmentation of the cheeks, fat grafting is an autologous alternative to silicone malar implants, though results are less predictable. Custom 3D-printed implants represent the frontier of facial implant surgery for complex reconstructive cases requiring precise skeletal contour restoration.

Custom implants manufactured using CT scan-derived three-dimensional computer modelling represent the current standard for complex facial skeletal reconstruction, offering patient-specific contouring that standard off-the-shelf silicone implants cannot achieve. The implant material selection — solid silicone, high-density polyethylene (Medpor), or titanium mesh — is based on the anatomical site, required mechanical properties, and surgeon experience. Implant pocket design and fixation method (screw fixation versus friction fit) significantly influence long-term implant stability and the risk of migration.

Facial implants provide permanent, dimensionally stable augmentation of the targeted skeletal region, producing reliable and enduring improvement in facial proportion. Patient satisfaction rates for chin implants are among the highest in cosmetic surgery — consistently above 88–92% in outcome studies — reflecting the significant visual impact of chin projection on overall facial aesthetics. Cheek implants produce meaningful improvement in facial midface definition and a more youthful appearance for patients with genetically flat cheekbones.

Results are permanent in the sense that properly placed, well-tolerated implants remain indefinitely without degrading. Unlike soft tissue fillers — which require repeated injection at 12–18 month intervals — a single implant procedure provides lifelong structural augmentation at a fraction of the cumulative cost of repeated filler treatments. Facial balance improvement achieved through implants also enhances the results of concurrent rhinoplasty, facelift, or other facial procedures by correcting the underlying skeletal proportions before addressing overlying soft tissue features.

Infection is the most serious early complication of facial implants, occurring in approximately 1–3% of cases. Intraoral incision placement creates inherent bacterial contamination risk, managed with pre-operative prophylactic antibiotics and meticulous surgical technique. Established implant infection typically requires implant removal, antibiotic treatment, and re-implantation after 3–6 months. Haematoma or seroma formation occurs in approximately 1–2% of cases.

Implant migration or malposition is possible if fixation is inadequate, producing asymmetry or discomfort requiring revision. Sensory changes — numbness of the lower lip or chin (from mental nerve proximity during chin implant placement) — occur in approximately 15–20% of patients, with most recovering within 3–6 months. Permanent mental nerve sensory loss is uncommon (less than 3%). Implant palpability (feeling the implant edge beneath the skin) may occur with thin-skinned patients. Bone resorption beneath the implant, caused by pressure on the underlying periosteum, is a well-recognised long-term phenomenon that is generally clinically insignificant with properly designed implants placed in the subperiosteal plane.

Recovery from facial implant surgery varies by implant location. Chin implants via intraoral approach cause local swelling, numbness, and tightness for 2–4 weeks. Patients are maintained on a soft diet for 2 weeks and must rinse with antiseptic mouthwash after meals for 2 weeks while the intraoral wound heals. Cheek implants cause periorbital swelling and bruising that resolves over 2–3 weeks. External sutures (if used) are removed at 7 days; intraoral sutures are typically resorbable.

Return to office work is typically possible within 1–2 weeks for chin implants and 1–2 weeks for cheek implants when swelling has sufficiently reduced. Strenuous exercise is avoided for 3–4 weeks. Contact sports and facial trauma risk activities should be avoided for 6 weeks until the implant has settled and fibrous capsule formation has secured its position. Follow-up at 1 week, 4 weeks, 3 months, and 6 months assesses implant position, soft tissue healing, nerve recovery, and final aesthetic outcome.

Facial implant costs depend on implant type (standard vs. custom), the number of implants placed, surgical facility, and geographic location. In the United States, chin implant surgery typically costs USD 3,000–6,500 and cheek augmentation USD 3,500–7,000. Combined chin and cheek implants cost USD 7,000–14,000. Custom facial implants for complex cases add USD 3,000–8,000 for the fabrication cost alone.

At leading plastic surgery centres in India (Mumbai, Delhi, Bangalore), single facial implant procedures cost USD 800–2,500, and combined chin and cheek implants USD 2,000–5,000. In Thailand (Bangkok), costs are USD 1,500–4,000 for combined implants. In Turkey, USD 1,500–3,500. In South Korea (Seoul) — a global hub for facial aesthetic surgery — combined facial implants cost USD 3,000–7,000 with exceptionally high surgical standards. Patients save 50–75% compared to US costs while accessing board-certified surgeons with extensive facial implant experience.

For chin augmentation, the primary surgical alternative to alloplastic implant is the sliding genioplasty, which repositions the chin bone through an osteotomy and provides three-dimensional correction including vertical and transverse adjustments not achievable with implant alone. Genioplasty is preferred for patients with severe microgenia, combined vertical and horizontal deficiency, and those who are undergoing orthognathic surgery for malocclusion correction simultaneously.

Non-surgical alternatives include hyaluronic acid filler injection for temporary chin and cheek augmentation, lasting 12–18 months and providing a reversible way to assess the aesthetic effect of structural augmentation before committing to surgery. Fat grafting offers an autologous alternative for both cheek and chin volume enhancement with natural tissue feel, though predictability of volume retention is lower than implants. Botulinum toxin injection into the masseter muscles reduces lower facial width for patients whose concern is an overly square jaw rather than insufficient jaw projection.